CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist
  • 196.63
  • -2.87-1.44%
Market Closed Dec 20 15:00 CST
78.85BMarket Cap20.75P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
109.83M
--
+64.78%
EPS
--
-1.50
--
--
Analyst Rating
Strong Buy

Dec 22, 2024

Sichuan Biokin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 2.413B --
-- 2024/FY -- / 6.174B --
-- 2023/FY 561.871M / 562.000M --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.413B--
--2024/FY-- / 6.174B--
--2023/FY561.871M / 562.000M--
--------
--------

Unlock Free Earnings Estimates

Sichuan Biokin Pharmaceutical Earnings Reports

  • Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 29 00:00

  • Sichuan Baili Tianheng Pharmaceutical Co., Ltd. Report for the third quarter of 2024

    Oct 29 00:00

  • Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 24 00:00

  • Summary of the half-year report for Sichuan Baili Tianheng Pharmaceutical Co., Ltd. in 2024

    Aug 24 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data